BRPI0810003A2 - "produção de proteínas de alta manose em cultura de plantas" - Google Patents

"produção de proteínas de alta manose em cultura de plantas"

Info

Publication number
BRPI0810003A2
BRPI0810003A2 BRPI0810003-9A BRPI0810003A BRPI0810003A2 BR PI0810003 A2 BRPI0810003 A2 BR PI0810003A2 BR PI0810003 A BRPI0810003 A BR PI0810003A BR PI0810003 A2 BRPI0810003 A2 BR PI0810003A2
Authority
BR
Brazil
Prior art keywords
production
high mannose
plant culture
mannose proteins
proteins
Prior art date
Application number
BRPI0810003-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Yoseph Shaaltiel
Gideon Baum
Daniel Bartfeld
Sharon Hashmueli
Ayala Lewkowicz
Original Assignee
Protalix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protalix Ltd filed Critical Protalix Ltd
Publication of BRPI0810003A2 publication Critical patent/BRPI0810003A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2465—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01022—Alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01045—Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
BRPI0810003-9A 2007-04-30 2008-04-30 "produção de proteínas de alta manose em cultura de plantas" BRPI0810003A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/790,991 US7951557B2 (en) 2003-04-27 2007-04-30 Human lysosomal proteins from plant cell culture
PCT/IL2008/000576 WO2008132743A2 (en) 2007-04-30 2008-04-30 Production of high mannose proteins in plant culture

Publications (1)

Publication Number Publication Date
BRPI0810003A2 true BRPI0810003A2 (pt) 2015-07-21

Family

ID=39929901

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810003-9A BRPI0810003A2 (pt) 2007-04-30 2008-04-30 "produção de proteínas de alta manose em cultura de plantas"

Country Status (12)

Country Link
US (8) US7951557B2 (enExample)
EP (1) EP2220105A4 (enExample)
JP (1) JP2010525806A (enExample)
KR (1) KR20100023833A (enExample)
CN (1) CN101855232A (enExample)
AU (1) AU2008243744A1 (enExample)
BR (1) BRPI0810003A2 (enExample)
CA (1) CA2685400A1 (enExample)
MX (1) MX2009011751A (enExample)
RU (1) RU2009143751A (enExample)
WO (1) WO2008132743A2 (enExample)
ZA (1) ZA200908423B (enExample)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032211A1 (en) * 1996-09-26 2005-02-10 Metabogal Ltd. Cell/tissue culturing device, system and method
IL155588A0 (en) * 2003-04-27 2003-11-23 Metabogal Ltd Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
US20030100945A1 (en) * 2001-11-23 2003-05-29 Mindguard Ltd. Implantable intraluminal device and method of using same in treating aneurysms
US20100196345A1 (en) * 2003-04-27 2010-08-05 Protalix Production of high mannose proteins in plant culture
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
KR20080083060A (ko) * 2006-01-04 2008-09-12 베링거 인겔하임 인터내셔날 게엠베하 중등 지속성 천식의 치료에서 티오트로퓸 염의 용도
ES2660667T3 (es) 2007-05-07 2018-03-23 Protalix Ltd. Biorreactor desechable a gran escala
DK2169054T3 (en) * 2007-07-03 2016-03-07 Idemitsu Kosan Co A vaccine against edema disease in swine
US8742079B2 (en) 2007-08-20 2014-06-03 Protalix Ltd. Saccharide-containing protein conjugates and uses thereof
CA2787099A1 (en) 2009-03-30 2010-10-14 Anice C. Lowen Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
AU2010281403B2 (en) 2009-07-28 2016-03-10 Takeda Pharmaceutical Company Limited Compositions and methods for treating Gaucher disease
CA2773133A1 (en) 2009-08-28 2011-03-03 Edward H. Schuchman Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
US9194011B2 (en) 2009-11-17 2015-11-24 Protalix Ltd. Stabilized alpha-galactosidase and uses thereof
WO2011061736A1 (en) 2009-11-17 2011-05-26 Protalix Ltd. Alkaline alpha galactosidase for the treatment of fabry disease
CA2782269C (en) * 2009-12-01 2019-06-11 Shire Human Genetic Therapies, Inc. Enzymatic activity based-detection
US20130017169A1 (en) 2010-03-02 2013-01-17 Protalix Ltd. Multimeric forms of therapeutic proteins and uses thereof
DK2865751T3 (en) 2010-03-02 2017-01-09 Protalix Ltd Stabilized alpha-galactosidase and uses thereof
US20130198897A1 (en) * 2010-03-22 2013-08-01 Philip Morris Products S.A. Modifying enzyme activity in plants
WO2011123495A1 (en) 2010-03-30 2011-10-06 Mount Sinai School Of Medicine Influenza virus vaccines and uses thereof
CN103154243A (zh) 2010-10-15 2013-06-12 日本化学研究株式会社 糖链的非还原末端为甘露糖残基的糖蛋白的制造方法
EP2471929A1 (en) * 2010-12-29 2012-07-04 Algenics Production of high mannose glycosylated proteins stored in the plastid of microalgae
EP2665814B1 (en) * 2011-01-20 2017-05-17 Protalix Ltd. Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
JP5809817B2 (ja) * 2011-03-09 2015-11-11 本田技研工業株式会社 タンパク質の植物細胞内への蓄積方法
EP2718459B1 (en) 2011-06-08 2018-02-28 Shire Human Genetic Therapies, Inc. Competition-based detection assays
EP2758075B1 (en) 2011-09-20 2023-05-03 Icahn School of Medicine at Mount Sinai Influenza virus vaccines and uses thereof
WO2013114371A1 (en) 2012-02-01 2013-08-08 Protalix Ltd. Dry powder formulations of dnase i
IN2014MN01806A (enExample) 2012-02-19 2015-07-03 Protalix Ltd
WO2013130963A1 (en) 2012-03-02 2013-09-06 Shire Human Genetic Therapies, Inc. Compositions and methods for treating type iii gaucher disease
CN112400900A (zh) 2012-03-09 2021-02-26 韦斯塔隆公司 毒肽产生、植物中的肽表达和富含半胱氨酸的肽的组合
US11692016B2 (en) 2012-03-09 2023-07-04 Vestaron Corporation High gene expression yeast strain
EP2662083A1 (en) 2012-05-08 2013-11-13 CSL Behring GmbH Sugar compositions for treating hemophilia a and/or von willebrand disease
EP2934581B1 (en) 2012-12-18 2022-09-14 Icahn School of Medicine at Mount Sinai Influenza virus vaccines and uses thereof
EP2964668B1 (en) 2013-03-06 2019-11-27 Protalix Ltd. Tnf alpha inhibitor polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
US9908930B2 (en) 2013-03-14 2018-03-06 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
US20170101633A1 (en) 2014-02-10 2017-04-13 Protalix Ltd. Method of maintaining disease stability in a subject having gaucher's disease
US10000551B2 (en) 2014-09-11 2018-06-19 Protalix Ltd. Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
JP2018504412A (ja) 2015-01-23 2018-02-15 アイカーン スクール オブ メディシン アット マウント サイナイ インフルエンザウイルスワクチン接種レジメン
AU2016232149B2 (en) 2015-03-17 2021-09-23 eleva GmbH Glycosylated lysosomal proteins, method of production and uses
US9981021B1 (en) 2015-04-09 2018-05-29 Kinetiq, Inc. Subcutaneous therapeutic enzyme formulations, uses, and methods for generating thereof
GB201508025D0 (en) 2015-05-11 2015-06-24 Ucl Business Plc Fabry disease gene therapy
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US10761054B2 (en) * 2016-05-13 2020-09-01 Agilent Technologies, Inc. Systems and methods for automated alignment, calibration and standardization of electrophoresis data
EP3471767A4 (en) 2016-06-15 2020-01-15 Icahn School of Medicine at Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
US11535653B2 (en) * 2016-10-21 2022-12-27 Vestaron Corporation Cleavable peptides and insecticidal and nematicidal proteins comprising same
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2018187706A2 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
EA202091032A1 (ru) 2017-10-26 2020-07-17 Шайр Хьюман Дженетик Терапиз, Инк. Составы, содержащие глюкоцереброзидазу и изофагомин
WO2019246363A1 (en) 2018-06-21 2019-12-26 Icahn School Of Medicine At Mount Sinai Mosaic influenza virus hemagglutinin polypeptides and uses thereof
CN111826391B (zh) * 2019-03-29 2023-01-31 中国科学院分子植物科学卓越创新中心 一种nhx2-gcd1双基因或其蛋白的应用
WO2020219719A1 (en) 2019-04-24 2020-10-29 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
US20220325265A1 (en) * 2019-09-09 2022-10-13 Hoffmann-La Roche Inc. Glucocerebrosidase mutants
CN115003328A (zh) 2019-10-22 2022-09-02 西奈山伊坎医学院 重组神经氨酸酶及其用途
WO2021216621A2 (en) 2020-04-20 2021-10-28 Vestaron Corporation Proteolytically stable u1-agatoxin-ta1b variant polypeptides for pest control
BR112023001456A2 (pt) 2020-07-27 2023-04-11 Voyager Therapeutics Inc Composições e métodos para o tratamento de distúrbios neurológicos relacionados à deficiência de beta glicosilceramidase
JP2024535811A (ja) 2021-09-13 2024-10-02 プランティバディーズ 組換えタンパク質作製のための遺伝子改変された生物
US20250049955A1 (en) 2021-11-17 2025-02-13 Voyager Therapeutics, Inc. Compositons and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
WO2025019631A1 (en) 2023-07-19 2025-01-23 Icahn School Of Medicine At Mount Sinai Immunogenic compositions containing inactivated influenza a virus and cpg oligonucleotide adjuvant and uses thereof
CN120695154A (zh) * 2025-08-28 2025-09-26 山东大学 豌豆肽在制备防治卵巢损伤药物中的应用

Family Cites Families (192)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053848A (enExample)
US609654A (en) * 1898-08-23 Cradle
US467993A (en) 1892-02-02 Alfred jorgensen
US27127A (en) 1860-02-14 Fiee-escape
US2147271A (en) 1937-07-16 1939-02-14 Schwarz Lab Inc Pure yeast culture apparatus
US2341259A (en) 1941-01-22 1944-02-08 Lummus Co Inoculating method and apparatus
US2504185A (en) * 1945-04-27 1950-04-18 Carnegie Illinois Steel Corp Method for making basic furnace bottoms
US2836434A (en) 1952-08-21 1958-05-27 Separator Ab Arrangement for sterile interconnection and sealing of apparatuses in a plant for instance for cultivation of bacteria
US3201327A (en) 1962-08-21 1965-08-17 Sun Oil Co Fermentation apparatus and process
SE371208B (enExample) 1966-10-06 1974-11-11 Sanraku Ocean Co
US3468520A (en) 1967-05-12 1969-09-23 American Cyanamid Co Combination agitation and transfer unit for suspended cells
US3504185A (en) 1968-05-09 1970-03-31 Univ Syracuse Res Corp Apparatus for measuring and controlling cell population density in a liquid medium
GB1284077A (en) 1968-10-18 1972-08-02 British Petroleum Co Process and apparatus for the cultivation of micro-organisms
US3540700A (en) 1969-01-24 1970-11-17 New Brunswick Scientific Co Rotary processing apparatus
DE2059931C3 (de) 1970-12-05 1973-10-18 Knapsack Ag, 5033 Huerth-Knapsack Verfahren zum Verhindern von Schaumausbrüchen aus geschlossenen Reaktionsräumen
US3793154A (en) 1970-12-21 1974-02-19 Univ St Johns Apparatus for gaseous environmental control of batch cultures of micro-organisms
US3950227A (en) 1970-12-21 1976-04-13 St. John's University Batch method of establishing and maintaining a controlled aerobic environment for a microbial culture
CS192067B1 (en) 1975-12-02 1979-08-31 Drahoslav Pravda Separation blood bag for the sterile preparation of the blood serum for single use
US4179339A (en) 1977-03-02 1979-12-18 Olympus Optical Company, Ltd. Liquid feeder for automatic culture apparatus
US4228243A (en) 1978-07-13 1980-10-14 Toray Industries, Inc. Cell culture propagation apparatus
US4328317A (en) 1980-03-31 1982-05-04 Solargizer International, Inc. Continuous chemical conversion or fermentation apparatus
DE3133314A1 (de) 1981-08-22 1983-03-10 Hoechst Ag, 6000 Frankfurt "vorrichtung zum dispergieren einer zweiten phase in einer ersten phase"
US4425908A (en) 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4519984A (en) 1982-01-18 1985-05-28 Phillips Petroleum Company Apparatus for carrying out sparged reaction
SE445884B (sv) 1982-04-30 1986-07-28 Medinvent Sa Anordning for implantation av en rorformig protes
CH663422A5 (de) 1982-05-27 1987-12-15 Chemap Ag Verfahren und fermenter zur zuechtung von gewebezellen.
US4643184A (en) 1982-09-29 1987-02-17 Mobin Uddin Kazi Embolus trap
US4708938A (en) 1984-04-30 1987-11-24 Hickinbotham Winemakers Pty. Ltd. Alcoholic fermentation
DK151404C (da) 1984-05-23 1988-07-18 Cook Europ Aps William Sammenklappeligt filter til implantation i en patients blodkar
EP0183372A1 (en) 1984-10-19 1986-06-04 RAYCHEM CORPORATION (a Delaware corporation) Prosthetic stent
JPH0446128Y2 (enExample) 1984-10-29 1992-10-29
US4577631A (en) 1984-11-16 1986-03-25 Kreamer Jeffry W Aneurysm repair apparatus and method
DE3577578D1 (de) 1985-02-01 1990-06-13 Maerkl Herbert Folienfermenter.
US4668632A (en) 1985-02-06 1987-05-26 Vxr, Inc. Sparger and apparatus for and method of growing cells
SE450809B (sv) 1985-04-10 1987-08-03 Medinvent Sa Plant emne avsett for tillverkning av en spiralfjeder lemplig for transluminal implantation samt derav tillverkad spiralfjeder
US5372945A (en) 1985-06-06 1994-12-13 Alchas; Paul G. Device and method for collecting and processing fat tissue and procuring microvessel endothelial cells to produce endothelial cell product
CN85100412B (zh) 1985-06-25 1988-02-10 山东省食品发酵工业研究所 用嗜热放线菌生产固定化葡萄糖异构酶的方法及其用于高果糖糖浆的生产方法
US4713345A (en) 1985-07-29 1987-12-15 Grain Processing Corporation Fermentation methods and apparatus
EP0224962A1 (en) 1985-11-25 1987-06-10 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Apparatus for the continuous cultivation of microorganisms in a culture liquid
SE453258B (sv) 1986-04-21 1988-01-25 Medinvent Sa Elastisk, sjelvexpanderande protes samt forfarande for dess framstellning
US5166072A (en) 1986-06-26 1992-11-24 Bayer Aktiengesellschaft Apparatus for the cultivation of immobilized micro-organisms
SE453752B (sv) 1986-07-04 1988-02-29 Alfa Laval Food & Dairy Eng Forfarande och anordning for aseptisk overforing av en vetskemengd, serskilt vid provtagning
JPS63109772U (enExample) 1986-08-21 1988-07-14
JPS63109772A (ja) 1986-10-28 1988-05-14 Nitto Electric Ind Co Ltd 植物細胞等の培養方法
JPS63133978A (ja) * 1986-11-26 1988-06-06 Rikagaku Kenkyusho 細胞培養装置
US4717668A (en) 1986-12-12 1988-01-05 Baxter Travenol Laboratories, Inc. Plastic roller bottle for suspension cultures
US5081036A (en) 1987-01-23 1992-01-14 Hoffmann-La Roche Inc. Method and apparatus for cell culture
US4908315A (en) 1987-03-04 1990-03-13 Agristar, Inc. Integument and method for micropropagation and tissue culturing
GB2202549A (en) 1987-03-20 1988-09-28 Philip John Whitney Foldable fermenter
US4894344A (en) 1987-11-28 1990-01-16 Nippon Shinyaku Co., Ltd. Method for manufacturing 2-amino-2-deoxy-D-mannitol
US6846968B1 (en) 1988-02-26 2005-01-25 Large Scale Biology Corporation Production of lysosomal enzymes in plants by transient expression
IL86442A (en) 1988-05-19 1992-02-16 Plant Biotec Ltd Air lift fermenter formed from flexible plastic sheets
DE3823711C1 (enExample) 1988-07-13 1990-04-12 Chemap Ag, Volketswil, Ch
US4931401A (en) 1988-09-01 1990-06-05 La Societe De Recherche Snc Inc. Bioreactor
JPH02119771A (ja) 1988-10-29 1990-05-07 Nitto Denko Corp 細胞培養方法及びこの方法で使用する細胞培養用撹拌翼
US5549892A (en) * 1988-12-23 1996-08-27 Genzyme Corporation Enhanced in vivo uptake of glucocerebrosidase
US5073491A (en) 1988-12-23 1991-12-17 Hoffman-La Roche Inc. Immobilization of cells in alginate beads containing cavities for growth of cells in airlift bioreactors
US5188946A (en) 1989-01-26 1993-02-23 Biocontrol Systems Incorporated Process and device for sequential microbial enrichment in a single apparatus
US5100801A (en) 1989-01-26 1992-03-31 Biocontrol Systems, Inc. Device for sequential microbial enrichment in a single apparatus
US5843089A (en) 1990-12-28 1998-12-01 Boston Scientific Corporation Stent lining
JPH0418055Y2 (enExample) 1990-02-28 1992-04-22
EP0447256A3 (en) 1990-03-16 1992-01-08 Hitachi, Ltd. Methods and apparatus for incubation and sterilization
JP2514102B2 (ja) 1990-06-13 1996-07-10 ユリカ株式会社 ユリ科アロエ属に属する植物の真空凍結乾燥体を利用した錠剤製品及びその製造方法
EP0462065B1 (de) 1990-06-15 2005-03-02 Syngenta Participations AG Neue Signalsequenzen
EP0471947A1 (en) 1990-06-29 1992-02-26 Sekisui Chemical Co., Ltd. Culture bag
US5240598A (en) 1990-09-18 1993-08-31 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Microbubble generator for the transfer of oxygen to microbial inocula and microbubble generator immobilized cell reactor
US5401650A (en) 1990-10-24 1995-03-28 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active α-galactosidase A
EP0485970A3 (en) 1990-11-13 1992-07-01 Yeda Research And Development Company Limited Transgenic plants overproducing threonine and lysine
AT394576B (de) 1991-01-16 1992-05-11 Vogelbusch Gmbh Reaktor zur durchfuehrung biologischer reaktionen mittels biokatalysatoren
US5350398A (en) 1991-05-13 1994-09-27 Dusan Pavcnik Self-expanding filter for percutaneous insertion
US5304220A (en) 1991-07-03 1994-04-19 Maginot Thomas J Method and apparatus for implanting a graft prosthesis in the body of a patient
US5415630A (en) 1991-07-17 1995-05-16 Gory; Pierre Method for removably implanting a blood filter in a vein of the human body
US5612188A (en) 1991-11-25 1997-03-18 Cornell Research Foundation, Inc. Automated, multicompartmental cell culture system
US5267791A (en) 1991-12-13 1993-12-07 Corning Incorporated Suspended cell culture stirring vessel closure and apparatus
JPH05219834A (ja) 1992-02-14 1993-08-31 Fumiko Kobayashi ディスポーサブル培養袋及び培養方法
GB9209993D0 (en) 1992-05-08 1992-06-24 Munn Edward A Vaccines
IL102189A (en) 1992-06-12 1995-07-31 Univ Ben Gurion Device for growing microorganisms
US5324304A (en) 1992-06-18 1994-06-28 William Cook Europe A/S Introduction catheter set for a collapsible self-expandable implant
US5562725A (en) 1992-09-14 1996-10-08 Meadox Medicals Inc. Radially self-expanding implantable intraluminal device
US5383392A (en) 1993-03-16 1995-01-24 Ward Holding Company, Inc. Sheet registration control
US5409833A (en) 1993-07-01 1995-04-25 Baxter International Inc. Microvessel cell isolation apparatus
US5464449A (en) 1993-07-08 1995-11-07 Thomas J. Fogarty Internal graft prosthesis and delivery system
US5342781A (en) 1993-07-15 1994-08-30 Su Wei Wen W External-loop perfusion air-lift bioreactor
US5723004A (en) 1993-10-21 1998-03-03 Corvita Corporation Expandable supportive endoluminal grafts
US5443497A (en) 1993-11-22 1995-08-22 The Johns Hopkins University Percutaneous prosthetic by-pass graft and method of use
DE69533964T2 (de) 1994-10-24 2006-03-30 The Texas A & M University System, College Station Orale immunisierung durch verwendung von transgenen pflanzen
DE69521331T2 (de) 1994-11-01 2001-09-20 Winfried Wels Nukleinsäure-einbringungssystem
DE4441792A1 (de) 1994-11-24 1996-05-30 Bosch Gmbh Robert Brennstoffeinspritzvorrichtung für eine Brennkraftmaschine
US5549626A (en) 1994-12-23 1996-08-27 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Vena caval filter
GB2298577B (en) 1995-03-09 1999-02-17 Univ Bristol Arteriovenous bypass grafting
US5725568A (en) 1995-06-27 1998-03-10 Scimed Life Systems, Inc. Method and device for recanalizing and grafting arteries
EP0865499B1 (en) 1995-09-14 2009-03-18 Virginia Tech Intellectual Properties, Inc. Production of lysosomal enzymes in plant-based expression systems
US5769816A (en) 1995-11-07 1998-06-23 Embol-X, Inc. Cannula with associated filter
EP0775471B1 (en) 1995-11-27 2002-05-29 Schneider (Europe) GmbH A stent for use in a body passage way
US6576009B2 (en) 1995-12-01 2003-06-10 Medtronic Ave, Inc. Bifurcated intraluminal prostheses construction and methods
WO1997029200A1 (de) 1996-02-08 1997-08-14 Institut für Pflanzengenetik und Kulturpflanzenforschung Kassetten zur expression von lagerstabilen proteinen in pflanzen
US5871537A (en) 1996-02-13 1999-02-16 Scimed Life Systems, Inc. Endovascular apparatus
US5891191A (en) 1996-04-30 1999-04-06 Schneider (Usa) Inc Cobalt-chromium-molybdenum alloy stent and stent-graft
US5800514A (en) 1996-05-24 1998-09-01 Meadox Medicals, Inc. Shaped woven tubular soft-tissue prostheses and methods of manufacturing
JPH1084802A (ja) 1996-09-11 1998-04-07 Science & Tech Agency ニンジン不定胚の大量培養方法
US6458574B1 (en) 1996-09-12 2002-10-01 Transkaryotic Therapies, Inc. Treatment of a α-galactosidase a deficiency
US6083725A (en) 1996-09-13 2000-07-04 Transkaryotic Therapies, Inc. Tranfected human cells expressing human α-galactosidase A protein
US20050032211A1 (en) 1996-09-26 2005-02-10 Metabogal Ltd. Cell/tissue culturing device, system and method
IL119310A (en) 1996-09-26 1999-07-14 Metabogal Ltd Cell/tissue culturing device and method
IL155588A0 (en) * 2003-04-27 2003-11-23 Metabogal Ltd Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
US5876367A (en) 1996-12-05 1999-03-02 Embol-X, Inc. Cerebral protection during carotid endarterectomy and downstream vascular protection during other surgeries
US5807330A (en) 1996-12-16 1998-09-15 University Of Southern California Angioplasty catheter
US5919224A (en) 1997-02-12 1999-07-06 Schneider (Usa) Inc Medical device having a constricted region for occluding fluid flow in a body lumen
US5814064A (en) 1997-03-06 1998-09-29 Scimed Life Systems, Inc. Distal protection device
US5853419A (en) 1997-03-17 1998-12-29 Surface Genesis, Inc. Stent
US5817126A (en) 1997-03-17 1998-10-06 Surface Genesis, Inc. Compound stent
US6048360A (en) 1997-03-18 2000-04-11 Endotex Interventional Systems, Inc. Methods of making and using coiled sheet graft for single and bifurcated lumens
WO1998046168A1 (en) 1997-04-15 1998-10-22 Schneider (Usa) Inc Prostheses with selectively welded crossing strands
US5843172A (en) 1997-04-15 1998-12-01 Advanced Cardiovascular Systems, Inc. Porous medicated stent
JP4083241B2 (ja) 1997-04-23 2008-04-30 アーテミス・メディカル・インコーポレイテッド 分岐ステント及び遠位保護システム
US6258120B1 (en) 1997-12-23 2001-07-10 Embol-X, Inc. Implantable cerebral protection device and methods of use
CA2424551A1 (en) 1997-05-27 1998-11-27 Schneider (Usa) Inc. Stent and stent-graft for treating branched vessels
JPH1112143A (ja) 1997-06-20 1999-01-19 Lion Corp 口腔用組成物
US5951599A (en) 1997-07-09 1999-09-14 Scimed Life Systems, Inc. Occlusion system for endovascular treatment of an aneurysm
US5928260A (en) 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
DE69834920T2 (de) 1997-08-05 2007-05-24 Boston Scientific Ltd., St. Michael Ablösbares system zum verschliessen eines aneurysmashalses
ATE526818T1 (de) 1997-08-12 2011-10-15 Univ North Carolina State Gentechnisch hergestellte wasserlinse
US6190913B1 (en) 1997-08-12 2001-02-20 Vijay Singh Method for culturing cells using wave-induced agitation
US6086577A (en) 1997-08-13 2000-07-11 Scimed Life Systems, Inc. Detachable aneurysm neck bridge (III)
US5855599A (en) 1997-09-02 1999-01-05 Sitek, Inc. Silicon micro machined occlusion implant
US5941896A (en) 1997-09-08 1999-08-24 Montefiore Hospital And Medical Center Filter and method for trapping emboli during endovascular procedures
US6030414A (en) 1997-11-13 2000-02-29 Taheri; Syde A. Variable stent and method for treatment of arterial disease
US6022374A (en) 1997-12-16 2000-02-08 Cardiovasc, Inc. Expandable stent having radiopaque marker and method
US5964798A (en) 1997-12-16 1999-10-12 Cardiovasc, Inc. Stent having high radial strength
US5976169A (en) 1997-12-16 1999-11-02 Cardiovasc, Inc. Stent with silver coating and method
US5927988A (en) 1997-12-17 1999-07-27 Jenkins; William M. Method and apparatus for training of sensory and perceptual systems in LLI subjects
US6096546A (en) * 1998-01-30 2000-08-01 Board Of Trustees, Rutgers, The State University Of New Jersey Methods for recovering polypeptides from plants and portions thereof
JP4204752B2 (ja) 1998-02-12 2009-01-07 マロッタ、トーマス・アール 血管内補綴物
ATE439446T1 (de) 1998-06-22 2009-08-15 Ca Minister Agriculture & Food Herstellung von il-10 in einen pflanzenbioreaktor aus pflanzen, die nicht zur ernährung verwendet werden
US5928261A (en) 1998-06-29 1999-07-27 Ruiz; Carlos E. Removable vascular filter, catheter system and methods of use
US6093199A (en) 1998-08-05 2000-07-25 Endovascular Technologies, Inc. Intra-luminal device for treatment of body cavities and lumens and method of use
JP3689802B2 (ja) 1998-08-06 2005-08-31 株式会社ロッテ 歯牙エナメル質の再石灰化促進剤及び口腔用組成物並びに飲食物
US6117117A (en) 1998-08-24 2000-09-12 Advanced Cardiovascular Systems, Inc. Bifurcated catheter assembly
AU6021699A (en) 1998-09-01 2000-03-21 Penn State Research Foundation Method and apparatus for aseptic growth or processing of biomass
BR9915919A (pt) 1998-10-07 2001-08-21 Syngenta Participations Ag Proteìnas terapeuticamente ativas em plantas
JP3689803B2 (ja) 1998-10-20 2005-08-31 株式会社ロッテ 歯牙エナメル質の再石灰化促進剤及び口腔用組成物並びに飲食物
US6528063B2 (en) 1999-01-04 2003-03-04 Rahan Meristem Recombinant vaccines against IBDV
US6432698B1 (en) 1999-01-06 2002-08-13 Rutgers, The State University Disposable bioreactor for culturing microorganisms and cells
EP1148839B1 (en) 1999-02-01 2008-09-10 Board Of Regents, The University Of Texas System Woven bifurcated and trifurcated stents and methods for making the same
US20040167613A1 (en) 1999-03-11 2004-08-26 Ofer Yodfat Implantable stroke prevention device
US6673089B1 (en) 1999-03-11 2004-01-06 Mindguard Ltd. Implantable stroke treating device
IL128938A0 (en) 1999-03-11 2000-02-17 Mind Guard Ltd Implantable stroke treating device
US6146370A (en) 1999-04-07 2000-11-14 Coaxia, Inc. Devices and methods for preventing distal embolization from the internal carotid artery using flow reversal by partial occlusion of the external carotid artery
NL1012782C2 (nl) 1999-08-05 2001-02-06 Keygene Nv Verbeterde gfp-variant, bruikbaar als markering, en gfp-construct.
US6409757B1 (en) 1999-09-15 2002-06-25 Eva Corporation Method and apparatus for supporting a graft assembly
US6383171B1 (en) 1999-10-12 2002-05-07 Allan Will Methods and devices for protecting a passageway in a body when advancing devices through the passageway
US20020127219A1 (en) 1999-12-30 2002-09-12 Okkels Jens Sigurd Lysosomal enzymes and lysosomal enzyme activators
IL150314A0 (en) 1999-12-30 2002-12-01 Maxygen Aps Improved lysosomal enzymes and lysosomal enzyme activators
US20040010307A1 (en) 2000-01-18 2004-01-15 Mindguard Ltd. Implantable integral device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation
US20040010308A1 (en) 2000-01-18 2004-01-15 Mindguard Ltd. Implantable composite device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation
US6312463B1 (en) 2000-02-01 2001-11-06 Endotex Interventional Systems, Inc. Micro-porous mesh stent with hybrid structure
JP2002000248A (ja) 2000-06-23 2002-01-08 Daiichi Kagaku Kk 凍結法及び凍結乾燥法
IL137326A0 (en) 2000-07-17 2001-07-24 Mind Guard Ltd Implantable braided stroke preventing device and method of manufacturing
NZ523912A (en) * 2000-07-31 2005-03-24 Biolex Inc Expression of biologically active polypeptides in duckweed
US7138262B1 (en) 2000-08-18 2006-11-21 Shire Human Genetic Therapies, Inc. High mannose proteins and methods of making high mannose proteins
EP1409695A2 (en) 2000-11-15 2004-04-21 Genzyme Corporation Expression system for recombinant proteins
ATE540120T1 (de) 2000-11-17 2012-01-15 Danisco Us Inc Manipulation des phenolsäuregehalts und der verdaubarkeit von pflanzenzellwänden durch gezielte expression von genen, die zellwandabbauende enzyme kodieren
JP2002238580A (ja) 2001-02-20 2002-08-27 Naoyuki Taniguchi 動物型糖鎖付加機能を持つ植物細胞
US6488704B1 (en) 2001-05-07 2002-12-03 Biomed Solutions, Llc Implantable particle measuring apparatus
ATE440144T1 (de) 2001-04-18 2009-09-15 Vlaams Interuniv Inst Biotech Die verwendung von abc transporter kodierenden genen zur stimulierung der herstellung von sekundärmetaboliten in biologischen zellen
US7629309B2 (en) 2002-05-29 2009-12-08 Zystor Therapeutics, Inc. Targeted therapeutic proteins
US20030100945A1 (en) 2001-11-23 2003-05-29 Mindguard Ltd. Implantable intraluminal device and method of using same in treating aneurysms
CA2353307A1 (fr) 2001-07-13 2003-01-13 Carmen Parent Appareil et procede pour le traitement des effluents gazeux
WO2003013598A2 (en) 2001-08-09 2003-02-20 Lam Dominic M K Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases
US6638294B1 (en) 2001-08-30 2003-10-28 Advanced Cardiovascular Systems, Inc. Self furling umbrella frame for carotid filter
ITRM20020115A1 (it) 2002-03-01 2003-09-01 Plantechno S R L Espressione di enzimi lisosomiali in seme.
ES2224792B1 (es) 2002-06-28 2007-02-16 Era Plantech, S.L. Produccion de peptidos y proteinas por acumulacion de cuerpos proteicos derivados de reticulos endoplasmico en plantas.
CA2491690C (en) 2002-07-03 2016-10-18 University Of Central Florida Somatogenic plastid transformation
US7316774B2 (en) 2002-07-22 2008-01-08 Kinetico Incorporated Fluid treatment system
US7951557B2 (en) 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
US7296856B2 (en) * 2003-10-08 2007-11-20 Pride Mobility Products Corporation Reclining seat with movable back support
AU2004287645A1 (en) 2003-11-06 2005-05-19 Compugen Ltd. Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
US20090130704A1 (en) 2003-11-13 2009-05-21 Gyure Dale C Novel bioreactor
EP1687393B1 (en) 2003-11-18 2012-03-07 Nestec S.A. System for cell culture
TWI228313B (en) * 2003-11-21 2005-02-21 Hannstar Display Corp Pixel and repairing method thereof
EP1763575A4 (en) 2004-04-27 2009-09-23 Baxter Int REACTOR SYSTEM WITH AGITATION RESERVOIR
ES2306010T3 (es) 2004-06-02 2008-11-01 Millipore Corporation Biorreactor desechable.
CN101001945B (zh) 2004-06-04 2012-02-08 艾克塞勒雷克斯公司 一次性生物反应器系统及方法
JP2008515478A (ja) 2004-10-03 2008-05-15 セルジ ゴールドマン， 多皮質歯科用インプラントアンカー、歯科用インプラントキット及びテンプレート
KR20070085291A (ko) * 2004-10-13 2007-08-27 프로탈릭스 리미티드 식물 세포 배양에서 항체를 생산하는 시스템 및 방법
WO2007005882A2 (en) * 2005-07-05 2007-01-11 North Carolina State University Methods and compositions for expressing proteins in plants
KR20080038131A (ko) * 2005-07-18 2008-05-02 프로탈릭스 리미티드 생물학적으로 활성인 거대분자의 점막 또는 장관 투여
US20070102128A1 (en) * 2005-11-10 2007-05-10 Levit Mikhail R Wood pulp paper with high antimicrobial barrier level
US8470584B2 (en) 2006-05-10 2013-06-25 Ohio University Apparatus and method for growing biological organisms for fuel and other purposes
US20080132743A1 (en) 2006-12-01 2008-06-05 Albemarle Corporation Production of high purity decabromodiphenylalkanes
ES2660667T3 (es) 2007-05-07 2018-03-23 Protalix Ltd. Biorreactor desechable a gran escala
US8956823B2 (en) 2007-08-20 2015-02-17 Bio-Rad Laboratories, Inc. Anti-antibody reagent

Also Published As

Publication number Publication date
US9220737B2 (en) 2015-12-29
AU2008243744A1 (en) 2008-11-06
RU2009143751A (ru) 2011-06-10
US20160095907A1 (en) 2016-04-07
EP2220105A2 (en) 2010-08-25
CA2685400A1 (en) 2008-11-06
KR20100023833A (ko) 2010-03-04
US7951557B2 (en) 2011-05-31
CN101855232A (zh) 2010-10-06
EP2220105A4 (en) 2011-01-19
US8227230B2 (en) 2012-07-24
US20110182868A1 (en) 2011-07-28
WO2008132743A2 (en) 2008-11-06
US8741620B2 (en) 2014-06-03
MX2009011751A (es) 2010-02-22
US20090208477A1 (en) 2009-08-20
US20110250181A1 (en) 2011-10-13
US8790641B2 (en) 2014-07-29
US20130177538A1 (en) 2013-07-11
US20080038232A1 (en) 2008-02-14
ZA200908423B (en) 2010-12-29
JP2010525806A (ja) 2010-07-29
WO2008132743A3 (en) 2010-06-03
US8449876B2 (en) 2013-05-28
US20120282231A1 (en) 2012-11-08
US20140271577A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
ZA200908423B (en) Production of high mannose proteins in plant culture
IL182888A0 (en) Production of high mannose proteins in plant culture
EP2064942A4 (en) PLANTS GROWING SYSTEM
PL2192911T3 (pl) Roślinny ekstrakt z konopi ubogich w THC do leczenia chorób
EP1984509A4 (en) PREPARATION OF FOREIGN NUCLEIC ACIDS AND POLYPEPTIDES IN PLANT SYSTEMS
EP1955586A4 (en) PLANT BREEDING UNIT AND PLANT BODY
SMT201700529T1 (it) Metodi per un'aumentata produzione di proteine
EP1973429A4 (en) PROTEIN HYDROLYSATES AND MANUFACTURING METHOD THEREFOR
BRPI0817392A2 (pt) "processo de fermentação e instalação cervejeira"
EP2195348A4 (en) PREPARATION OF HYALURONIC ACID
HRP20182165T1 (hr) Postupak proizvodnje polipeptida ili virusa od interesa u kontinuiranoj staničnoj kulturi
EP2440035A4 (en) METHOD FOR TRANSIENT EXPRESSION OF NUCLEIC ACIDS IN PLANTS
EP2096647A4 (en) PROCESS FOR PREPARING A POLYELECTROLYTMEMBRANE AND POLYELECTROLYTMEMBRANE
EP2014315A4 (en) PROCESS FOR THE PRODUCTION OF ARTIFICIAL BONE
EP2285824A4 (en) PREPARATION OF PROTEIN ISOLATES
PT2005817T (pt) Método de cultivo de plantas
SMT201600147B (it) Metodi per migliorare l'espressione di proteine ricombinanti
DE602006014483D1 (de) Gewebekulturmikroskop
EP2016087A4 (en) hydrogenation
IT1392177B1 (it) Impianto e processo per la produzione di biogas
BRPI0814249A2 (pt) Produção de proteínas em plantas
BR112012009820A2 (pt) "substituto de refeição e processo de preparação de um substituto de refeição "
FI20060954A0 (fi) Sakeutuslaite ja -menetelmä
ITMO20070138A1 (it) "impianto di macinazione"
FR2944794B1 (fr) Procede de preparation d'oligomeres de glycoside de flavonoide et utilisation en cosmetique.

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.